When subjects were divided into four groups according to BMI and estrogen (E2) stratified by the median values, the highest value for serum RBP4 was in subjects with both obesity and the low estrogen level, the lowest value was in non-obese groups with high estrogen level. Here, RBP4 is linked to obesity due to melanocortin 4 receptor deficiency.